Yahoo answers: What's the difference between eczema and psoriasis?
-
I am looking to really understand the difference, if anyone knows, can you tell me?
01/31/07 -
psoriasis is a chronic, recurrent disorder. classic lesion is a well marginated, erythematous(red) plaque with silvery-white surface scale. distribution includes extensor surfaces like knees,...
Latest news about chronic plaque psoriasis
-
Xeljanz sNDA Accepted for Review for Plaque Psoriasis
Pfizer announced that the Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) for Xeljanz (tofacitinib citrate) 5mg and 10mg tablets for the treatment of adults with moderate to severe chronic plaque
Source: http://www.empr.com/xeljanz-snda-accepted-for-review-for-plaque-psoriasis/article/396574/ -
Ustekinumab Safe and Effective for the Treatment of Plaque Psoriasis
Patients were candidates for treatment “if they had been previously diagnosed of having moderate-severe chronic plaque psoriasis, with a PASI ≥10 or a body surface area ≥10%, and had shown either failure to respond to, or a contraindication to,
Source: http://www.hcplive.com/articles/Ustekinumab-Safe-and-Effective-for-the-Treatment-of-Plaque-Psoriasis -
Novartis (NVS) Reports FDA Approval Cosentyx for Moderate-to-Severe Plaque ...
Affecting 7.5 million Americans, psoriasis is a chronic immune-mediated disease characterized by thick and extensive skin lesions (plaques), which can cause itching, scaling, and pain and may negatively impact daily life. Nearly 35% of psoriasis
Source: http://www.streetinsider.com/Corporate%2BNews/Novartis%2B(NVS)%2BReports%2BFDA%2BApproval%2BCosentyx%2Bfor%2BModerate-to-Severe%2BPlaque%2BPsoriasis/10181873.html -
Health Canada to review Cipher's self-adhesive medicated plaster, Beteflam Patch
The Beteflam Patch is a novel, patent-protected, self-adhesive medicated plaster containing 0.1% betamethasone valerate, for the treatment of inflammatory skin conditions such as chronic plaque psoriasis ("CPP"). Topical corticosteroids remain the
Source: http://www.news-medical.net/news/20150213/Health-Canada-to-review-Ciphere28099s-self-adhesive-medicated-plaster-Beteflam-Patch.aspx -
Cipher Pharmaceuticals Announces Beteflam Patch Accepted For Review By ...
"Chronic plaque psoriasis is the most prevalent form of psoriasis, found in about 90% of subjects with the disease, and can profoundly impact the quality of life for patients," said Shawn O'Brien, President & Chief Executive Officer of Cipher. "If
Source: http://www.stockhouse.com/news/press-releases/2015/02/12/cipher-pharmaceuticals-announces-beteflam-patch-accepted-for-review-by-health
Images chronic plaque psoriasis




http://en.wikipedia.org/wiki/Plaque_psoriasis
http://www.aafp.org/afp/2006/0215/p636.html
http://www.patient.co.uk/doctor/chronic-plaque-psoriasis
http://dermatology.about.com/od/psoriasis/a/PlaquePsoriasis.htm
http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0013188/